Revelation Biosciences Inc
REVB
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.71M
Close$
$1.60
41.9% upside
Current Fair Value
41.9% upsideUndervalued by 41.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.71 Million |
|---|---|
| Enterprise Value | $-9,641,372.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-23.95 |
| Beta | -0.12 |
| Outstanding Shares | 3,207,720 |
Return
| Return on Equity | -114471.39% |
|---|---|
| Return on Assets | -98832.47% |
| Return on Invested Capital | -109049.52% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | 0.28 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.08 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-1.15
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.83
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Revelation Biosciences Inc
2 employees